Pronova BioPharma appoints Per-Oluf Olsen as new CEO
Per-Oluf Olsen, aged 52, will assume the role of CEO with effect from 17 November 2008. He joins Pronova BioPharma after 27 years with Pfizer Inc., where he gained extensive international experience in sales, marketing and management. Most recently, Mr. Olsen was regional executive director for Central and Eastern European region, inclusive regional office in Brussels. He was previously country manager for Pfizer in Italy, Norway and Denmark and has held a number of senior sales and marketing positions for the company in Norway and the USA.
Tomas Settevik will be proposed to be elected as a new board member at the annual general meeting in May 2009.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.